Immunis

Healthcare & Life Sciences

Recent Finacing

Recent Raise

Immunis, Inc. is a biotech company developing stem cell-derived biologics to treat age-related muscle atrophy and metabolic dysfunction.

Total Funding

Headquarters

Founded

Website

Focus Areas

Biotech

clinical-stage

immunomodulatory therapies

age-related muscle atrophy

metabolic dysfunction

stem cell-derived

Investors